About
Articles by Melanie
-
As vaccines approach, will we all stick together?
As vaccines approach, will we all stick together?
By Melanie Senior
-
Move over, Pfizer: Moderna grabs vaccine spotlight
Move over, Pfizer: Moderna grabs vaccine spotlight
By Melanie Senior
Activity
-
Over the last 7 years we’ve built Theolytics from concept to clinic. Thank you Hays and George Costard for inviting me to share some of those…
Over the last 7 years we’ve built Theolytics from concept to clinic. Thank you Hays and George Costard for inviting me to share some of those…
Liked by Melanie Senior
-
I bloody love working with our team of outrageously clever people on Evaluate Ltd's annual World Preview report (although, by thunder, it makes me…
I bloody love working with our team of outrageously clever people on Evaluate Ltd's annual World Preview report (although, by thunder, it makes me…
Liked by Melanie Senior
-
We mobilise to (very effectively) fight an invisible virus over 24 months. Yet we struggle to address a more visible, long-lasting health challenge…
We mobilise to (very effectively) fight an invisible virus over 24 months. Yet we struggle to address a more visible, long-lasting health challenge…
Shared by Melanie Senior
Experience & Education
Courses
-
Postgraduate Certificate in Applied Sports Nutrition (St. Mary's University)
-
-
Teaching English as a Foreign Language
-
Languages
-
French, German, Spanish
-
More activity by Melanie
-
Really looking forward to this....Good news at last?
Really looking forward to this....Good news at last?
Shared by Melanie Senior
-
We at MEDiSTRAVA were honoured to sponsor the Media Commentator Award at this year’s European Mediscience Awards 2024, celebrating outstanding…
We at MEDiSTRAVA were honoured to sponsor the Media Commentator Award at this year’s European Mediscience Awards 2024, celebrating outstanding…
Liked by Melanie Senior
-
Move over, antibody–drug conjugates. Targeted radiopharmaceuticals are the new favorite. Here's what radiopharma leaders are saying: “You get a…
Move over, antibody–drug conjugates. Targeted radiopharmaceuticals are the new favorite. Here's what radiopharma leaders are saying: “You get a…
Shared by Melanie Senior
-
Delighted to share our latest results from our collaboration with Ultragenyx
Delighted to share our latest results from our collaboration with Ultragenyx
Liked by Melanie Senior
-
BMS/RayzeBio's actinium-225 shortage plays into a fascinating alpha-isotope battle ongoing within radiopharmaceuticals: Act-225 or Pb (lead)-212? A…
BMS/RayzeBio's actinium-225 shortage plays into a fascinating alpha-isotope battle ongoing within radiopharmaceuticals: Act-225 or Pb (lead)-212? A…
Shared by Melanie Senior
-
Fabulous to join you for such an exciting occasion- in honour of such a brilliant scientist. I was kept on my toes with the excellent audience…
Fabulous to join you for such an exciting occasion- in honour of such a brilliant scientist. I was kept on my toes with the excellent audience…
Liked by Melanie Senior
-
Keytruda is indeed a one-off. But let's not put the full blame on Uncle IRA. Science has something to say, too. As discussed in "What Next In…
Keytruda is indeed a one-off. But let's not put the full blame on Uncle IRA. Science has something to say, too. As discussed in "What Next In…
Shared by Melanie Senior
-
👏 I’m excited to be here @ASCO24 📍Looking forward to meeting you at Inizio booth #37157
👏 I’m excited to be here @ASCO24 📍Looking forward to meeting you at Inizio booth #37157
Liked by Melanie Senior
-
I must share as I am bursting w pride. My Bella just graduated w her Masters thesis at CBS. Congratulations with your Amazing effort and result.…
I must share as I am bursting w pride. My Bella just graduated w her Masters thesis at CBS. Congratulations with your Amazing effort and result.…
Liked by Melanie Senior
-
Ligand design is one of several innovation areas within the hot radiopharma space. Aktis offers Lilly "mini-proteins"; Mariana Oncology was touting…
Ligand design is one of several innovation areas within the hot radiopharma space. Aktis offers Lilly "mini-proteins"; Mariana Oncology was touting…
Shared by Melanie Senior
-
Another great week 🙂 for Optimum Strategic Communications as our podcast is highlighted by pharmaphorum as an invaluable resource for gaining…
Another great week 🙂 for Optimum Strategic Communications as our podcast is highlighted by pharmaphorum as an invaluable resource for gaining…
Liked by Melanie Senior
-
The UK’s place as a global leader in life sciences is there for the taking. This Spotlight podcast from The New Statesman explores strategies for…
The UK’s place as a global leader in life sciences is there for the taking. This Spotlight podcast from The New Statesman explores strategies for…
Liked by Melanie Senior
Other similar profiles
-
Richard Girling
Connect -
Paul Hudson
Connect -
Ansbert Gadicke, M.D.
Connect -
Paul Verdin
VP, Head of Consulting & Analytics at Evaluate Ltd
Connect -
Axel Haupt
Connect -
Norman Sharpless
Former Director, the National Cancer Institute; Jupiter BioVentures
Connect -
Vanessa Carle
Senior Associate at Forbion | Biotech Venture Capital
Connect -
Dror Schwartz
Investor
Connect -
Patrick Erne
Research & Investment Management bei Reichmuth & Co Privatbankiers
Connect -
Stella Xu
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Melanie Senior in United Kingdom
-
Melanie Senior
Drugs Practitioner at Multiple Choice
-
Melanie Senior
Passenger Information Assistant at West Yorkshire Combined Authority
-
Melanie Senior
Administration Officer at The Snaith School
-
MELANIE SENIOR
Alternative Dispute Resolution Professional
7 others named Melanie Senior in United Kingdom are on LinkedIn
See others named Melanie Senior